What 'pharmaceutical-grade' actually means.
From research-grade to GMP-certified: why controlled-substance drug manufacture is a different category of work — and why commercial access programs require it.
Sterile cultivation
Proprietary mushroom strains are grown on sterilized substrate in Class-B cleanroom conditions. Genetic consistency drives alkaloid yield.
Harvest & extraction
Fruiting bodies are harvested at peak alkaloid content, dried under controlled humidity, and extracted using validated solvents with food-grade GMP solvents and a documented COA at each stage.
Analytical QC
HPLC-MS confirms identity and potency of psilocybin and related alkaloids. USP-grade impurity panels screen heavy metals, pesticides, and residual solvents.
Encapsulation
Dose-titrated capsules are filled on dedicated equipment under full production-batch records. Content uniformity is verified to pharmacopoeial standards.
QP release & distribution
A qualified person signs batch release per Health Canada DEL requirements. Shipment occurs under chain-of-custody controls direct to licensed access-program partners.
- Single-batch characterization acceptable
- Impurity specs set by lab-to-lab practice
- Paper trail ends at the researcher
- No obligation to a regulator beyond the IRB
- Every batch follows validated production procedures
- Pharmacopoeial impurity panels (USP/EP equivalents)
- Complete batch records, audited quarterly
- Regulator-facing QP release; Dealer's Licence conditions